Patient demographics across preimplementation, during-implementation, and postimplementation of e-ordering periods
| Class/statistic | Preimplementation (n=25 912) | During-implementation (n=26 671) | Postimplementation (n=26 177) | Total (N=78 760) | |
| Gender (%) | Male | 14 451 (56) | 14 873 (56) | 14 684 (56) | 44 008 (56) |
| Female | 11 460 (44) | 11 796 (44) | 11 493 (44) | 34 749 (44) | |
| Non-binary | 1 (0) | 2 (0) | 0 (0) | 3 (0) | |
| Missing | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Age | Mean (SD) | 59.8 (19.9) | 59.9 (19.8) | 59.9 (19.8) | 59.9 (19.8) |
| Median (min, max) | 63 (18, 104) | 63 (18, 103) | 63 (18, 102) | 63 (18, 104) | |
| Diabetic (%) | No | 20 826 (80) | 21 203 (80) | 20 687 (79) | 62 716 (80) |
| Yes | 5085 (20) | 5467 (20) | 5489 (21) | 16 041 (20) | |
| Missing | 1 (0) | 1 (0) | 1 (0) | 3 (0) | |
| CCI score | Mean (SD) | 0.9 (1.5) | 1 (1.6) | 1 (1.5) | 1 (1.5) |
| Median (min, max) | 0 (0, 12) | 0 (0, 12) | 0 (0, 13) | 0 (0, 13) | |
| LOS days | Mean (SD) | 4.6 (5.6) | 4.5 (5.3) | 4.6 (5.3) | 4.6 (5.4) |
| Median (min, max) | 3 (1, 158) | 3 (1, 108) | 3 (1, 98) | 3 (1, 158) |
CCI, Charlson Comorbidity Index; LOS, length of stay.